首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1619047

细胞治疗技术市场规模、份额、成长分析、按类型、按工艺、按细胞类型、按最终用户、按地区 - 行业预测，2024-2031 年

Cell Therapy Technologies Market Size, Share, Growth Analysis, By Type, By Process, By Cell Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 201 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年细胞治疗技术的全球市场规模为39亿美元，从2023年的44.3亿美元成长到2031年的121.9亿美元，并且预计在预测期内（2024-2031年）将持续成长。为13.50%。

在临床研究资金增加和实用生产指南建立的推动下，细胞治疗市场正在经历显着成长。高品质的研究正在推动治疗细胞开发的进步，从而导致市场占有率的显着增长。临床试验的增加主要得到私人和政府资助机构的支持，欧洲计划经常得到欧盟津贴的支持。例如，Achilles Therapeutics 于 2022 年 7 月获得了 420 万美元的 Horizon Europe 奖项，以进一步推进个人化医疗。此外，细胞治疗技术的进步，例如 CRISPR/Cas9 等基因编辑技术和自动化製造，正在提高细胞治疗的扩充性和品质。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Thermo Fisher Scientific, Inc.
Merck KGaA
Danaher Corporation
Lonza Group
Sartorius AG
Terumo BCT, Inc.
Becton Dickinson and Company
Fresenius SE & Co. KGaA
Avantor, Inc.
Bio-Techne
Corning Incorporated
Fujifilm Irvine Scientific
MaxCyte, Inc.
Werum IT Solutions
RoosterBio, Inc.
TrakCel
L7 Informatics, Inc.
Miltenyi Biotec BV & Co. KG
STEMCELL Technologies
GPI Iberia（formerly Hemasoft）

结论和建议

简介目录

Product Code: SQMIG35A2873

Global Cell Therapy Technologies Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.43 billion in 2023 to USD 12.19 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The cell therapy market is experiencing significant growth fueled by increased funding for clinical research and the establishment of practical guidelines for production. Robust quality research is driving the advancement of therapeutic cell development, resulting in a notable market share expansion. The rise in clinical trials is largely supported by both private and government funding agencies, with European projects frequently backed by EU grants; for instance, Achilles Therapeutics secured a $4.2 million Horizon Europe award in July 2022 to further personalized medicine. Additionally, advancements in cell therapy techniques, including gene editing technologies like CRISPR/Cas9 and automation in manufacturing, are enhancing the scalability and quality of cell therapies, while regulatory approvals remain a decisive factor in market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Therapy Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Therapy Technologies Market Segmental Analysis

Global Cell Therapy Technologies Market is segmented by Type, Process, Cell Type, End User, and region. Based on Type, the market is segmented into Media, sera, and reagents, Cell engineering products, Cell culture vessels, Cell therapy equipment, Systems & software, and Other products. Based on Process, the market is segmented into Cell Processing, Cell preservation, distribution, and handling, and Process monitoring & quality control. Based on Cell Type, the market is segmented into T cells, Stem cells, and Other cells. Based on End User, the market is segmented into Biopharmaceutical & biotechnology companies, CROs & CMOs, and Research institutes & cell banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Therapy Technologies Market

One of the key drivers fueling the expansion of the global cell therapy technologies market is the continuous emergence of innovative therapies. This growth is largely attributable to the frequent introduction of advanced technologies aimed at facilitating state-of-the-art treatments. Notably, the deployment of proprietary cell lines is recognized as an effective method for achieving a substantial target population for specific products. A prime example of this is Immunicum's utilization of Chimeric Antigen Receptor T cell (CAR-T) expansion, along with dendritic cell neoantigen presentation techniques and T-cell priming strategies, all of which significantly enhance the development of their immuno-oncology portfolio.

Restraints in the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market faces significant challenges due to a shortage of skilled labor. Despite notable technological progress and innovations in recent years, there remains a dearth of qualified personnel capable of operating sophisticated instruments like flow cytometers and spectrophotometers. These advanced tools produce substantial volumes of data, necessitating a high level of expertise for effective analysis and interpretation. This gap in skilled workforce not only hampers operational efficiency but also poses a barrier to the overall growth and advancement of the cell therapy sector, potentially limiting its ability to leverage technological advancements fully.

Market Trends of the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market is experiencing significant growth, driven by the increasing demand for advanced analytical tools that enhance quality control and improvement. Innovative diagnostics, imaging technologies, and robust data analytics facilitate the streamlined monitoring and characterization of cellular materials, ensuring enhanced efficacy and safety profiles. The development of new biomaterials and scaffolds for improved cell delivery and engraftment is garnering heightened interest, offering benefits like better biocompatibility and controlled release kinetics. Moreover, intensified collaboration between research institutions is fostering innovation, aiding the rapid translation of cell therapy technologies from laboratory research to clinical application, positioning this sector for continued expansion.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Cell Therapy Technologies Market Size by Product & CAGR (2024-2031)

Market Overview
Media, sera, and reagents
Cell engineering products
Cell culture vessels
Cell therapy equipment
- Cell Processing equipment
- Single-use equipment
- Other equipment
Systems & software
Other products

Global Cell Therapy Technologies Market Size by Process & CAGR (2024-2031)

Market Overview
Cell Processing
Cell preservation, distribution, and handling
Process monitoring & quality control

Global Cell Therapy Technologies Market Size by Cell Type & CAGR (2024-2031)

Market Overview
T cells
Stem cells
Other cells

Global Cell Therapy Technologies Market Size by End User & CAGR (2024-2031)

Market Overview
Biopharmaceutical & biotechnology companies
CROs & CMOs
Research institutes & cell banks

Global Cell Therapy Technologies Market Size & CAGR (2024-2031)

North America (Product, Process, Cell Type, End User)
- US
- Canada
Europe (Product, Process, Cell Type, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product, Process, Cell Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product, Process, Cell Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Process, Cell Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo BCT, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Irvine Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MaxCyte, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werum IT Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RoosterBio, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TrakCel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
L7 Informatics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec B.V. & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GPI Iberia (formerly Hemasoft)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments